Basilico et al. described that SOX2 maintains cancer stem cells (CSC) in OS and antagonizes the Hippo pathway by directly repressing two Hippo activators, NF2 and WWC1, leading to exaggerated YAP function. The gene discussed is YAP1; the disease is cancer.